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Costs of robotic-assisted versus traditional laparoscopy in endometrial cancer 
ABSTRACT 
Objectives The purpose of this study was to compare the costs of traditional laparoscopy and 
robotic-assisted laparoscopy in the treatment of endometrial cancer. 
Methods/materials A total of 101 patients with endometrial cancer were randomized to the 
study, and operated on starting from 2010 until 2013, at the Department of Obstetrics and 
Gynecology of Tampere University Hospital, Tampere, Finland. Costs were calculated based 
on internal accounting, hospital databases and purchase prices, and compared using intention 
to treat analysis. Main outcome measures were item costs and total costs related to the 
operation, including a six month postoperative follow-up. 
Results The total costs excluding late complications were 1928 € higher in the robotic group 
(median for traditional 5487 €, vs. robot median 7415 €, p <0.001). The difference was due to 
higher costs for instruments, equipment as well as to more expensive operating room (OR) and 
post-anesthesia care unit time. Traditional laparoscopy involved higher costs for operation 
personnel, general costs, medication used in the operation and surgeon, although these costs 
were not substantial. There was no significant difference in inpatient stay, laboratory, radiology, 
blood products or costs related to complications. 
Conclusions According to this study robotic-assisted laparoscopy is 35% more expensive than 
traditional laparoscopy in the treatment of endometrial cancer. The cost difference is mainly 
explained by amortization of the robot and its instrumentation. 
Keywords Robotic-assisted surgery, endometrial cancer, cost analysis, gynecologic oncology  
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Introduction 
Endometrial cancer is the most common gynecologic malignancy in the developed countries 
with 167,900 estimated new cases and 34,700 estimated deaths in 2012.1 Primary treatment of 
endometrial cancer is hysterectomy and bilateral salpingo-oophorectomy, commonly 
accompanied by pelvic or pelvic and para-aortic lymphadenectomy. 2 Surgical methods for 
treating endometrial cancer include laparotomy, traditional laparoscopy and robotic-assisted 
laparoscopy. According to cost effectiveness analysis by Leitao et al. laparotomy was the most 
expensive approach compared to traditional laparoscopy and robotic-assisted laparoscopy (total 
costs without equipment USD 24,433, USD 20,289 and USD 20,467 respectively).3 The robot 
platform has been in use at Tampere University Hospital since 2009 and the robot is used by 
urologists, gynecologists and thoracic surgeons, with an annual rate of 345-400 operations. 
The aim of this analysis was to compare the costs of conventional laparoscopy and robotic-
assisted laparoscopy in the treatment of endometrial cancer, to evaluate possible differences 
and identify factors influencing the costs within a randomized trial. 
Materials and Methods 
In a clinical trial 101 patients presenting with endometrial cancer were randomized into two 
arms, traditional laparoscopy (traditional, n=51) and robotic-assisted laparoscopy (robot, 
n=50). Inclusion criteria were a low-grade (Grade 1-2) endometrial cancer, a scheduled staging 
operation and a signed informed consent. Exclusion criteria included a narrow vagina or a 
uterus too large to be removed through the vagina and ineligibility for a deep Trendelenburg 
position. The details of the study population, randomization procedure and operations, have 
been described in detail previously.4 
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The operations were performed at a tertiary referral center, the Department of Obstetrics and 
Gynecology of Tampere University Hospital, Tampere, Finland in 2010-2013 by gynecologic 
oncologists with several years of experience with laparoscopic surgery. The study protocol was 
approved by the Research Ethics Committee of Tampere University Hospital (identification 
code ETL R10081) and is registered at www.clinicaltrials.gov (NCT 01466777). 
The costs were calculated retrospectively in euros. The cost variables are presented in Table 1. 
The patient data were collected from the operation and onwards over the subsequent follow-up 
period of six months. All contacts and procedures at follow-up hospitals (imaging studies, 
readmissions, operative treatment) were recorded. These contacts and the costs related to them 
were calculated in complications and are referred in this article also as late complications. In 
complication costs all expenses related to the contact have been taken into account. This 
includes also all out-patient visits which led or did not lead to any procedures. Patients contacted 
clinics for various reasons like swelling, bruises and vaginal bleeding among other complaints. 
Most of these were normal post-operative symptoms. Because of swelling in lower extremities, 
many patients underwent a Doppler ultrasound imaging to exclude deep venous thrombosis, 
with no findings. 4 
Public health care in Finland uses an internal accounting and billing system within the hospitals. 
Different hospital units offer services based on their expertise e.g. anesthetic services, operating 
room (OR) services, laboratory services and consultations provided by other specialties like 
urologic surgery. We searched the hospital databases, in order to retrieve the actual costs of 
each operation.  
The original expense data from 2012 was used as the basis for calculating costs for operation 
personnel, amortization of the laparoscopy towers and the robot console, OR-costs, medication 
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during the operation and general costs related to the hospital infrastructure. The 2012 expense 
data was chosen because it represents the mid-point of the study period. 
The amortization and use of an energy instrument in traditional laparoscopy group was also 
included in the instrument costs; an energy instrument was used in 15 operations, based on the 
operating surgeon’s judgment.  
Costs related to the instrumentation, inpatient stay, radiology and laboratory services as well as 
blood products were calculated or retrieved from the database according to the actual time 
(exact date or at least year) of the operation. Inpatient stay, radiology, laboratory and blood 
product expenses were retrieved from the internal accounting system. For disposable 
instruments and products we used the real hospital purchase costs, according to the reported 
data on each operation, and we included in every operation a basic array of instruments and 
equipment involved in the operative set-up. Traditional and robotic operations had a different 
basic package based on the needs of the operative method. For reusable instruments the 
maintenance costs were calculated. For robot instruments the cost of amortizing (maximum 10 
operations / instrument) and the maintenance costs were taken into account. 
The robot at Tampere University Hospital is the Da Vinci® S surgical system (Intuitive Surgical, 
Inc., Sunnyvale CA). It is a leased product with a 10-year contract. The annual leasing and 
maintenance costs are 196,000 € and 140,000 € respectively. We divided these costs with the 
total number of operations during the year 2012 to calculate the robot platform amortization 
cost per robot operation. 
One patient was originally randomized into the traditional laparoscopy group, but the surgeon 
decided to change the operative procedure to robotic-assisted laparoscopy due to obesity of the 
patient. Because of this randomization violation secondary analyses were performed besides 
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the primary intention-to-treat analysis: A per protocol analysis with groups based on the actual 
operative manner (this patient included in the robot arm), and also excluding this patient. 
Two patients from the traditional laparoscopy group who were not suitable for laparoscopic 
operation, were operated through laparotomy and their data was not analyzed in the study.4 
Consequently the final number of patients in the analysis was 49 in the traditional group and 50 
in the robotic-assisted group. 
Distributions of cost factors were shown by medians with interquartile ranges due to the skewed 
distributions and outliers. Differences between traditional and robotic-assisted laparoscopic 
surgical costs were analyzed by non-parametric independent-samples Mann-Whitney U test. 
Categorical variables were tested by Pearson chi-square test or by Fisher’s exact test if the 
expected values were too small. Statistical analyses were performed by IBM SPSS Statistics 
version 23 (IBM Corp., Armonk, NY). P-values less than 0.05 were considered statistically 
significant. 
Results 
Because there were no substantial differences in the results of the intention-to-treat and 
treatment received analyses, only the results of the intention-to-treat analysis are presented here. 
Results using the secondary analyses are given in the Supplemental Tables (S1-S4). 
The item costs were higher in the robotic-assisted laparoscopy arm for instruments, equipment 
and OR, as well as post-anesthesia care unit (PACU) (Table 2). Traditional laparoscopy had 
higher costs for operation personnel and medication, general costs and surgeon costs, but these 
differences were relatively small (Table 1 for variable definitions, Table 2). There were no 
significant differences in costs related to inpatient stay, laboratory and radiology services or 
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blood products. The median total costs for the robotic-assisted laparoscopy, including late 
complications were 2160 € higher than for traditional laparoscopy (1.4-fold, cost per operation 
7982 € vs. 5823 € respectively, Fig 1) 
There were five conversions to laparotomy in the traditional laparoscopy group and none in the 
robot group.4 The total costs without late complications for these patients were substantially 
higher than for the rest of the traditional laparoscopy patients (non-conversions Md 5352 € vs. 
conversions 7149 €, p<0.001) There was also a significant difference in the length of inpatient 
stay (Md 1 vs. 4 days, p <0.001), which increased the costs of the Inpatient stay (1114 € vs. 
2148 €, p=0.002). Moreover, there was a significant difference in PACU time (Md 2h22min vs. 
3h33min, p<0.001), which also affected the PACU costs (704 € vs. 938 € p<0.001). The median 
total costs related to the laparoscopy-laparotomy converted operations are close to the median 
total cost of the robot arm without complications (7415 €). 
Ten patients in the traditional group and 20 patients in the robot group contacted the follow-up 
hospitals or had complications reported. The related median costs were 766 € and 844 € per 
patient, respectively (p=0.530). 
The operative time as well as the OR time were significantly shorter in the robot group, while 
PACU time was shorter in the traditional group (Table 3). 4 
Although there was no significant difference in the median length of post-operative inpatient 
stay (Table 3), one patient in the traditional group was not discharged until on the 7th 
postoperative day. Physically the patient’s recovery from the surgery did not differ from that of 
other patients but the patient’s mental status did not allow discharge, and she was waiting for a 
transfer to a municipal hospital. This created an outlier in the Inpatient stay costs (3343 €). We 
were unable to calculate the costs of the following municipal hospital stay. 
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One patient in the robot group underwent embolization while she was in the PACU due to a 
bleeding complication. This patient stayed in the PACU for 16h2min causing an outlier in the 
PACU time and PACU costs (4492 €), as well as the embolization cost in the Radiology 
Department (2884 €). We included the costs (embolization, laboratory, radiology, PACU) in 
this patient’s primary operation period, not itemizing them stratified according to the 
complications, because it was difficult to reliably differentiate the costs of this complication 
from the costs of the surgery itself e.g. in the PACU costs. 
One patient in the robot group needed two re-operations due to a rectovaginal-fistula. This 
patient also had repeated imaging studies and readmissions because of the complication. These 
costs created an outlier in Complication costs (14,818 €). 
No postoperative deaths occurred during the study period nor were there any thromboembolic 
events during the follow-up.4 
There was no significant difference between the two arms in duration of sick-leave (Table 3). 
Most of the patients did not receive sick-leave as they were already retired. Consequently sick-
leave costs were not calculated in this analysis. 
Robot instrument cost per operation was 1030 € (including 4 basic instruments used in the 
operations) and the amortization cost of the robot console per operation was 939 € according to 
the 2012 expense data (taken into account in equipment and OR costs) On this basis we 
calculated costs per duration of OR time related amortization cost (5,95 €/min) and applied it 
individually for each operation in accordance with the operating time. Therefore the equipment 
and OR costs can for some patients be less than 939 € (range 844 €-1503 €). 
Conclusions 
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The median actual costs of the robotic-assisted laparoscopy were 1,928 € (35%) higher per 
patient than the costs related to traditional laparoscopy. Although direct international 
comparisons are difficult to make due to differences in national health care funding systems, 
our results seem to be comparable to findings in previous studies, showing robotic-assisted 
laparoscopy to be 17-33% more expensive.5, 6 Amortization of the robot console and costs 
involved with robot instrumentation are the major determinants of the incremental costs related 
to robotic-assisted surgery.5-9 Amortization can be minimized by increasing the number of 
operations. However, because a set of robot instruments can only be used in 10 operations the 
instrument costs are practically fixed. Although we have previously shown that the operation 
time is shorter in robotic-assisted than traditional laparoscopic operations4, the shorter operation 
time was not enough to balance out the costs of amortization of the robot console and the use 
of robot instruments. 
In Finland doctors and surgeons in the public health care receive a monthly salary instead of 
fee for service. This explains the lower labor cost of surgeon per operation compared to a 
previous US study.3 In our study the surgeon cost is related only to the duration of the operation. 
The major strength of this study is the randomized design, ensuring an unbiased comparison 
between the treatment arms. The learning curve effect was also minimized as robotic surgery 
for gynecologic indications was started at our hospital already in March 2009. We have 
previously shown that the learning curve for robotic surgery is relatively short or 10 
operations.10 Moreover our experience with laparoscopic surgery for endometrial cancer dates 
from 1990s. 11 Both operative techniques were therefore already well-established at the time the 
randomized trial was initiated. 
The two groups were well balanced in relation to all major patient characters.4 
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The costs were calculated in a detailed fashion for each operation based on actual cost items, 
including even from the surgeons’ gloves and threads used. 
During the time of the study design, the standard surgical treatment of endometrial cancer at 
our institution was hysterectomy, bilateral salpingo-oophorectomy and in most cases, pelvic 
lymphadenectomy (PLND). These three procedures were scheduled to be performed to all of 
the randomized patients. PLND was not performed on two patients in both arms (total n=4) due 
to a disseminated disease.4 
The costs of para-aortic lymphadenectomy (PALND) were not evaluated. Current guidelines 
encourage PALND besides PLND to be performed in patients with high-risk endometrial 
cancer.12 Because extending the lymphadenectomy to the para-aortic area makes traditional 
laparoscopy challenging to perform the cost difference might have been smaller if PALND 
were included in the randomized study design.13 
Although the number of patients was rather limited, the outliers encountered in some variables 
did not substantially affect the final results. 
There are some local factors that inevitably constrain the generalizability of the results. Our 
robot console and its PACU are located in a separate building apart from the Department of 
Obstetrics and Gynecology and its ORs. This increases the expenses due to additional PACU 
time. 
Quality of life was not investigated in this study, which can be considered a limitation. 
Laparoscopic approach has replaced laparotomy in the operative treatment for endometrial 
cancer.12 At present laparotomy should not be considered as the primary operation method 
anymore now that minimally invasive methods have been evolved.13, 14 Also according to a 
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recent study comparing the costs of robotic-assisted laparoscopic hysterectomy to open 
hysterectomy, laparotomy was more expensive, mainly due to longer inpatient stay.16 In the 
field of laparoscopy, the robotic-assisted technique has introduced many advantages like 
diminished blood loss, wristed instruments, three dimensional stereoscopic vision, better 
ergonomics for surgeon, and a shorter learning curve. 9,10,11,15, 17 This was reflected also in the 
present study, where no conversions to laparotomy had to be undertaken in the robot group as 
opposed to five conversions in the traditional group. The total costs of the converted operations 
were almost as high as the costs of the robotic-assisted operations (Md 7149 € vs. 7415 € 
respectively). 
In contrast to clinical operations performed for real patients, in which setting each robotic 
instrument can be used only ten times, in the preclinical training phase the same instruments 
can be used 30 times (data obtained during from robotic training at Tampere University 
Hospital, Da Vinci® S surgical system, Intuitive Surgical, Inc., Sunnyvale CA). If robotic 
instruments could also clinically be used 30 times it would decrease the instrument costs by 
688 €. On the other hand if the annual number of gynecological operations at our institution 
would be increased from 84 to 120, with three instead of two daily operation, the amortization 
costs would decrease by 282 € per operation. By such means the median total costs for robotic 
surgery would be 6,445 € and the difference between the two operation types would decrease 
to 17%. 
We were unable to assess patient outcomes in terms of quality-adjusted life-year (QALY) 
(because no obvious difference in complications or other patient outcomes were found), so real 
cost-effectiveness analysis was not possible. However, applying a cost-effectiveness threshold 
of 50,000 € per QALY to the observed cost difference of 2160 € per operation, it would mean 
that one QALY would need to be gained per 26 patients operated to reach the threshold. 
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The robotic-assisted technique in the staging of endometrial carcinoma (hysterectomy, bilateral 
salpingo-oophorectomy and pelvic lymphadenectomy) increases the total treatment costs by 
one third compared with the traditional technique. In our setting this translates into roughly 
2000 € per patient. For further research it would be beneficial to calculate the costs in similar 
form including the para-aortic lymphadenectomy.  
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LEGEND FOR THE FIGURE  
Figure 1. Cost variables, comparison. (Accompanying .tif-file) 
Figure 1 legend: 
Median values (€) 
OR=operating room 
PACU=post-anesthesia care unit 
*Nurses and an anesthesiologist 
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Tables 
Table 1, Variable definitions. 
Variables Both groups Traditional Robot Comment 
Instruments Disposable instruments and 
materials, maintenance costs 
for reusable instruments, 
OR supplies hemostatic 
matrix if used 
Energy 
instrument 
costs 
Instrument 
cost per 
operation 
(four basic 
instruments) 
 
Inpatient stay Room and board, ward 
personnel, ward basic 
medication 
   
Lab Based on the needed studies 
during operation and inpatient 
stay 
   
Radiology Based on the needed imaging 
studies during operation and 
inpatient stay 
   
Blood products Blood transfusions and lab 
samples related to preparation 
or transfusions 
   
Operation 
personnel 
0.5 anesthesiologist, 3.25 OR 
nurses for each operation 
  Related to 
OR time 
Equipment and 
OR 
Costs of running the OR and 
the fixed equipment 
Amortization 
of a basic 
laparoscopy 
tower 
Amortization 
of the robot 
console 
Related to 
OR time 
General costs Administrative costs, costs 
that cannot be calculated 
elsewhere 
  Related to 
OR time 
Operation 
medication 
Anesthesia costs and local 
anesthetics 
  Related to 
OR time 
Surgeon costs Two operating specialists   Related to 
operation 
time 
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PACU costs 0.3 nurses per patient and 
facilities 
  Related to 
PACU 
time 
Complications Additional clinical visits, 
readmissions, radiology 
   
OR=operating room 
PACU=post-anesthesia care unit 
 
  
18 
 
 Costs of robotic-assisted vs. traditional laparoscopy   
Table 2. Itemized median costs for traditional vs. robot-assisted laparoscopy for endometrial carcinoma, intention-to-treat analysis within the 
Tampere randomized trial, cost factors. 
Variables Traditional (n=49)  Robot (n=50)  Difference  
 Md € (IQR €) %  Md € (IQR €) %  € p 
Instruments 214 (171-421) 5.9  1,813 (1,798-1,817) 23.9  -1,599 <0.001 
Inpatient stay 1,387 (1,002-1,635) 25.2  1,092 (932-1,422) 15.8  295 0.130 
Lab 824 (457-918) 13.3  791 (526-909) 9.3  33 0.845 
Radiology 0 (0-37) 0.6  0 (0-0) 1.1  0 0.321 
Blood products 18 (17-35) 0.6  18 (0-40) 0.6  0 0.674 
Operation personnel* 844 (797-995) 16.2  729 (661-833) 9.7  115 <0.001 
Equipment and OR 232 (217-295) 4.7  1,172 (1,064-1,340) 15.7  -940 <0.001 
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General costs 78 (73-91) 1.5  67 (61-77) 0.9  11 <0.001 
Operation medication 91 (86-108) 1.8  79 (72-90) 1.1  12 <0.001 
Surgeon costs 896 (806-1,049) 17.0  735 (643-866) 9.8  161 <0.001 
PACU costs 704 (704-938) 13.3  938 (704-938) 12.1  -234 <0.001 
           
Total costs without late complications 5,487 (4,766-6,184)   7,415 (6,937-8,057)   -1,928 <0.001 
Complications 766 (349-1,532)   844 (421-2883)   -78 0.530 
Total costs with complications 5,823 (4,912-6,243)   7,983 (7,236-8,400)   -2,160 <0.001 
Md=median value 
IQR=interquartile range 
*Nurses and an anesthesiologist 
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OR=operating room 
PACU=post-anesthesia care unit 
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Table 3. Time-related items in traditional vs. robot-assisted laparoscopy for endometrial carcinoma 
in the Tampere randomized trial, intention-to-treat analysis. 
Variables  Traditional (n=49)  Robot (n=50)  
 Md (IQR)  Md (IQR) p 
Sick-leave, days 27.5 (n=12) (24-33)  28 (n=13) (25-29.5) 0.728 
OR time 3:48 (3:35-4:29)  3:17 (2:59-3:45) <0.001 
Operation time 2:50 (2:33-3:19)  2:19 (2:02-2:44) <0.001 
PACU time 2:36 (2:03-3:08)  3:05 (2:38-3:31) 0.001 
Discharge, days 2 (1-2)  1 (1-2) 0.215 
Md=median value 
IQR=interquartile range 
OR=operating room 
PACU=post-anesthesia care unit 
 
